OSL 0.00% 0.9¢ oncosil medical ltd

Ann: Positive PanCO trial update on resected cohort, page-2

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    So according to OSL release , the survival data are in line with what would be expected with neoadjuvant chemotherapy.
    - but in Panco trial these patients received neoadjuvant chemo plus oncosil device
    - so isn’t this just saying if results are in line with neoadjuvant chemo as OSL state, the device doesn’t add any further benefit over what you’d expect with chemo??
    - they should really present the median survival for all 10
    - to me these results are ok, and obviously good for the 6 who’ve made it this far- but overall not stand-out
    - why haven’t they provided updated survival for the whole study?
 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $30.58M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $191.9K 21.25M

Buyers (Bids)

No. Vol. Price($)
11 8525000 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 964494 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.